• Je něco špatně v tomto záznamu ?

Brain morphometry in hepatic Wilson disease patients

P. Rahimi, S. Mareček, R. Brůha, M. Dezortová, P. Sojka, M. Hájek, M. Skowrońska, Ł. Smoliński, P. Urbánek, T. Litwin, P. Dušek

. 2025 ; 48 (1) : e12814. [pub] 20241119

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc25002872

Grantová podpora
LX22NPO5107 (MEYS) - Financed by European Union - Next Generation EU Ministerstvo Školství, Mládeže a Tělovýchovy
IN 00023001 Ministerstvo Zdravotnictví Ceské Republiky
NV15-25602A Ministerstvo Zdravotnictví Ceské Republiky
MHCZ-DRO-VFN64165 Ministerstvo Zdravotnictví Ceské Republiky

Wilson disease (WD) primarily presents with hepatic and neurological symptoms. While hepatic symptoms typically precede the neurological manifestations, copper accumulates in the brain already in this patient group and leads to subclinical brain MRI abnormalities including T2 hyperintensities and atrophy. This study aimed to assess brain morphological changes in mild hepatic WD. WD patients without a history of neurologic symptoms and decompensated cirrhosis and control participants underwent brain MRI at 3T scanner including high-resolution T1-weighted images. A volumetric evaluation was conducted on the following brain regions: nucleus accumbens, caudate, pallidum, putamen, thalamus, amygdala, hippocampus, midbrain, pons, cerebellar gray matter, white matter (WM), and superior peduncle, using Freesurfer v7 software. Whole-brain analyses using voxel- and surface-based morphometry were performed using SPM12. Statistical comparisons utilized a general linear model adjusted for total intracranial volume, age, and sex. Twenty-six WD patients with mild hepatic form (30 ± 9 years [mean age ± SD]); 11 women; mean treatment duration 13 ± 12 (range 0-42) years and 28 healthy controls (33 ± 9 years; 15 women) were evaluated. Volumetric analysis revealed a significantly smaller pons volume and a trend for smaller midbrain and cerebellar WM in WD patients compared to controls. Whole-brain analysis revealed regions of reduced volume in the pons, cerebellar, and lobar WM in the WD group. No significant differences in gray matter density or cortical thickness were found. Myelin or WM in general seems vulnerable to low-level copper toxicity, with WM volume loss showing promise as a marker for assessing brain involvement in early WD stages.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25002872
003      
CZ-PrNML
005      
20250206103922.0
007      
ta
008      
250121s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/jimd.12814 $2 doi
035    __
$a (PubMed)39561975
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Rahimi, Parya $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia
245    10
$a Brain morphometry in hepatic Wilson disease patients / $c P. Rahimi, S. Mareček, R. Brůha, M. Dezortová, P. Sojka, M. Hájek, M. Skowrońska, Ł. Smoliński, P. Urbánek, T. Litwin, P. Dušek
520    9_
$a Wilson disease (WD) primarily presents with hepatic and neurological symptoms. While hepatic symptoms typically precede the neurological manifestations, copper accumulates in the brain already in this patient group and leads to subclinical brain MRI abnormalities including T2 hyperintensities and atrophy. This study aimed to assess brain morphological changes in mild hepatic WD. WD patients without a history of neurologic symptoms and decompensated cirrhosis and control participants underwent brain MRI at 3T scanner including high-resolution T1-weighted images. A volumetric evaluation was conducted on the following brain regions: nucleus accumbens, caudate, pallidum, putamen, thalamus, amygdala, hippocampus, midbrain, pons, cerebellar gray matter, white matter (WM), and superior peduncle, using Freesurfer v7 software. Whole-brain analyses using voxel- and surface-based morphometry were performed using SPM12. Statistical comparisons utilized a general linear model adjusted for total intracranial volume, age, and sex. Twenty-six WD patients with mild hepatic form (30 ± 9 years [mean age ± SD]); 11 women; mean treatment duration 13 ± 12 (range 0-42) years and 28 healthy controls (33 ± 9 years; 15 women) were evaluated. Volumetric analysis revealed a significantly smaller pons volume and a trend for smaller midbrain and cerebellar WM in WD patients compared to controls. Whole-brain analysis revealed regions of reduced volume in the pons, cerebellar, and lobar WM in the WD group. No significant differences in gray matter density or cortical thickness were found. Myelin or WM in general seems vulnerable to low-level copper toxicity, with WM volume loss showing promise as a marker for assessing brain involvement in early WD stages.
650    _2
$a lidé $7 D006801
650    12
$a hepatolentikulární degenerace $x patologie $x diagnostické zobrazování $7 D006527
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a dospělí $7 D000328
650    12
$a magnetická rezonanční tomografie $7 D008279
650    12
$a mozek $x patologie $x diagnostické zobrazování $7 D001921
650    _2
$a mladý dospělý $7 D055815
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a šedá hmota $x patologie $x diagnostické zobrazování $7 D066128
650    _2
$a bílá hmota $x patologie $x diagnostické zobrazování $7 D066127
650    _2
$a játra $x patologie $x diagnostické zobrazování $7 D008099
650    _2
$a lidé středního věku $7 D008875
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Mareček, Stanislav $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia
700    1_
$a Brůha, Radan $u Fourth Department of Internal Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia
700    1_
$a Dezortová, Monika $u MR Unit, Department of Diagnostic and Interventional Radiology, Institute for Clinical and Experimental Medicine, Prague, Czechia
700    1_
$a Sojka, Petr $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia
700    1_
$a Hájek, Milan $u MR Unit, Department of Diagnostic and Interventional Radiology, Institute for Clinical and Experimental Medicine, Prague, Czechia
700    1_
$a Skowrońska, Marta $u Second Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
700    1_
$a Smoliński, Łukasz $u Second Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
700    1_
$a Urbánek, Petr $u Department of Medicine, First Faculty of Medicine, Charles University and Military University Hospital, Prague, Czechia
700    1_
$a Litwin, Tomasz $u Second Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
700    1_
$a Dušek, Petr $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia $1 https://orcid.org/0000000348779642 $7 jo2013795390
773    0_
$w MED00002747 $t Journal of inherited metabolic disease $x 1573-2665 $g Roč. 48, č. 1 (2025), s. e12814
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39561975 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206103918 $b ABA008
999    __
$a ok $b bmc $g 2262959 $s 1238879
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 48 $c 1 $d e12814 $e 20241119 $i 1573-2665 $m Journal of inherited metabolic disease $n J Inherit Metab Dis $x MED00002747
GRA    __
$a LX22NPO5107 (MEYS) - Financed by European Union - Next Generation EU $p Ministerstvo Školství, Mládeže a Tělovýchovy
GRA    __
$a IN 00023001 $p Ministerstvo Zdravotnictví Ceské Republiky
GRA    __
$a NV15-25602A $p Ministerstvo Zdravotnictví Ceské Republiky
GRA    __
$a MHCZ-DRO-VFN64165 $p Ministerstvo Zdravotnictví Ceské Republiky
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...